MorphoSys (MOR) Short Interest Ratio & Short Volume $18.96 0.00 (0.00%) As of 04/1/2025 Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock MorphoSys Short Interest DataMorphoSys (MOR) has a short interest of 135,000 shares. This marks a -48.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 1.02 million shares to cover all short positions.Current Short Interest135,000 sharesPrevious Short Interest262,100 sharesChange Vs. Previous Month-48.49%Dollar Volume Sold Short$2.50 millionShort Interest Ratio0.6 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares150,621,000 sharesPercentage of Shares Shorted0.09%Today's Trading Volume0 sharesAverage Trading Volume1,019,393 sharesToday's Volume Vs. Average0% Short Selling MorphoSys? Sign up to receive the latest short interest report for MorphoSys and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMOR Short Interest Over TimeMOR Days to Cover Over TimeMOR Percentage of Float Shorted Over Time Remove Ads MorphoSys Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2024135,000 shares $2.50 million -48.5%N/A0.6 $18.55 6/30/2024262,100 shares $4.77 million -10.5%N/A0.9 $18.20 6/15/2024292,900 shares $5.31 million -65.0%N/A0.9 $18.14 5/31/2024837,600 shares $15.40 million -52.7%N/A2.1 $18.39 5/15/20241,770,000 shares $32.75 million +41.6%N/A4.1 $18.50 4/30/20241,250,000 shares $21.76 million -18.3%N/A0.9 $17.41 4/15/20241,530,000 shares $27.57 million -6.1%N/A0.8 $18.02 3/31/20241,630,000 shares $29.57 million -22.0%N/A0.8 $18.14 3/15/20242,090,000 shares $37.29 million +1.5%N/A1 $17.84 2/29/20242,060,000 shares $36.26 million -1.0%N/A0.9 $17.60 Get the Latest News and Ratings for MOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. 2/15/20242,080,000 shares $36.38 million +52.9%N/A0.8 $17.49 1/31/20241,360,000 shares $14.29 million +38.1%N/A0.5 $10.51 1/15/2024985,000 shares $8.47 million -31.6%N/A0.8 $8.60 12/31/20231,440,000 shares $14.26 million +9.9%N/A1.4 $9.90 12/15/20231,310,000 shares $12.73 million +1.6%N/A1.4 $9.72 11/30/20231,290,000 shares $8.82 million +255.2%N/A1.7 $6.84 11/15/2023363,200 shares $2.52 million +485.8%N/A0.8 $6.95 10/31/202362,000 shares $494,140.00 +12.3%N/A0.3 $7.97 10/15/202355,200 shares $358,800.00 -18.3%N/A0.3 $6.50 9/30/202367,600 shares $454,272.00 -44.9%N/A0.4 $6.72 9/15/2023122,700 shares $986,508.00 -4.3%N/A0.7 $8.04 8/31/2023128,200 shares $961,500.00 +10.2%N/A0.7 $7.50 8/15/2023116,300 shares $890,858.00 +96.8%N/A0.6 $7.66 7/31/202359,100 shares $434,385.00 +135.5%N/A0.3 $7.35 7/15/202325,100 shares $196,784.00 -45.6%N/A0.1 $7.84 6/30/202346,100 shares $344,367.00 +21.0%N/A0.3 $7.47 6/15/202338,100 shares $269,367.00 +359.0%N/A0.3 $7.07 5/31/20238,300 shares $53,203.00 -69.9%N/A0.1 $6.41 5/15/202327,600 shares $166,428.00 -7.1%N/A0.2 $6.03 4/30/202329,700 shares $155,628.00 +3.5%N/A0.2 $5.24 4/15/202328,700 shares $149,240.00 -13.3%N/A0.3 $5.20 3/31/202333,100 shares $131,076.00 +51.1%N/A0.2 $3.96 3/15/202321,900 shares $81,906.00 +14.1%N/A0.2 $3.74 2/28/202319,200 shares $86,400.00 -63.9%N/A0.1 $4.50 2/15/202353,200 shares $265,468.00 +2.3%N/A0.3 $4.99 1/31/202352,000 shares $257,400.00 -65.0%N/A0.3 $4.95 1/15/2023148,700 shares $679,559.00 +75.2%N/A0.8 $4.57 12/30/202284,900 shares $303,942.00 +57.2%N/A0.6 $3.58 12/15/202254,000 shares $215,460.00 +50.0%N/A0.4 $3.99 11/30/202236,000 shares $148,320.00 -0.6%N/A0.4 $4.12New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited. 11/15/202236,200 shares $142,266.00 -67.5%N/A0.4 $3.93 10/31/2022111,300 shares $538,692.00 -9.9%N/A1.7 $4.84 10/15/2022123,500 shares $659,490.00 -34.2%N/A2.2 $5.34 9/30/2022187,600 shares $943,628.00 +11.0%N/A4 $5.03 9/15/2022169,000 shares $870,350.00 -0.2%N/A4.3 $5.15 8/31/2022169,300 shares $746,613.00 -11.3%N/A2.7 $4.41 8/15/2022190,800 shares $1.17 million +70.8%N/A3.2 $6.14 7/31/2022111,700 shares $619,935.00 -6.4%N/A1.8 $5.55 7/15/2022119,300 shares $620,360.00 -12.5%N/A1.8 $5.20 6/30/2022136,400 shares $658,812.00 -4.9%N/A1.9 $4.83 6/15/2022143,400 shares $678,282.00 -18.4%N/A2 $4.73 5/31/2022175,800 shares $986,238.00 -5.1%N/A3.7 $5.61 5/15/2022185,200 shares $903,776.00 -6.8%N/A3.5 $4.88 4/30/2022198,600 shares $1.05 million +2.9%N/A3.5 $5.28 4/15/2022193,100 shares $1.25 million -6.2%N/A3.4 $6.46 3/31/2022205,800 shares $1.40 million -3.2%N/A3.3 $6.78 3/15/2022212,600 shares $1.34 million +13.4%N/A2.9 $6.32 2/28/2022187,500 shares $1.28 million +16.4%N/A1.9 $6.84 2/15/2022161,100 shares $1.21 million +23.5%N/A1.6 $7.48 1/31/2022130,500 shares $1.05 million +97.1%N/A1.3 $8.02 1/15/202266,200 shares $561,376.00 +79.4%N/A0.7 $8.48 12/31/202136,900 shares $347,598.00 -84.2%N/A0.4 $9.42 12/15/2021233,100 shares $2.15 million -4.7%N/A2.6 $9.21 11/30/2021244,500 shares $2.47 million +20.4%N/A3.6 $10.11 11/15/2021203,100 shares $2.20 million +34.7%N/A3.3 $10.85 10/29/2021150,800 shares $1.77 million +12.9%N/A2.7 $11.71 10/15/2021133,600 shares $1.54 million +14.0%N/A2.1 $11.53 9/30/2021117,200 shares $1.38 million -15.6%N/A1.6 $11.76 9/15/2021138,800 shares $1.69 million -10.1%N/A1.7 $12.20 8/31/2021154,300 shares $2.25 million -11.0%N/A1.4 $14.56 8/13/2021173,400 shares $2.37 million +1.8%N/A1.4 $13.67 7/30/2021170,400 shares $2.37 million +12.4%N/A1.4 $13.91 7/15/2021151,600 shares $2.58 million -7.5%N/A1.4 $17.00 6/30/2021163,900 shares $3.16 million +31.9%N/A1.7 $19.25 6/15/2021124,300 shares $2.43 million +114.7%N/A1.5 $19.52 5/28/202157,900 shares $1.28 million -46.8%N/A0.8 $22.08 5/14/2021108,900 shares $2.22 million +10.5%N/A1.7 $20.34 4/30/202198,600 shares $2.29 million -23.8%N/A1.5 $23.25 4/15/2021129,400 shares $2.94 million +24.8%N/A2 $22.69 3/31/2021103,700 shares $2.24 million -55.3%N/A1.6 $21.56 3/15/2021232,000 shares $5.90 million -29.2%N/A3.5 $25.43 2/26/2021327,800 shares $8.39 million +1.8%N/A6.2 $25.58 2/12/2021321,900 shares $9.36 million -2.0%N/A7.3 $29.09 1/29/2021328,600 shares $9.86 million -1.1%N/A7.1 $30.02 1/15/2021332,400 shares $9.50 million -8.4%N/A5.6 $28.59 12/31/2020362,800 shares $10.34 million +1.0%N/A6 $28.51 12/15/2020359,300 shares $10.04 million +3.0%N/A5.4 $27.94 11/30/2020349,000 shares $9.83 million +7.2%N/A5.5 $28.17 11/15/2020325,500 shares $8.44 million +14.5%N/A5.1 $25.94 10/30/2020284,400 shares $7.17 million -1.2%N/A4.4 $25.22New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited. 10/15/2020287,700 shares $8.27 million +5.6%N/A4 $28.74 9/30/2020272,500 shares $8.55 million +27.4%N/A3.4 $31.39 9/15/2020213,900 shares $6.91 million -4.3%N/A2.2 $32.31 MOR Short Interest - Frequently Asked Questions What is MorphoSys' current short interest? Short interest is the volume of MorphoSys shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 135,000 shares of MOR short. Learn More on MorphoSys' current short interest. What is a good short interest ratio for MorphoSys? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOR shares currently have a short interest ratio of 1.0. Learn More on MorphoSys's short interest ratio. Is MorphoSys' short interest increasing or decreasing? MorphoSys saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 135,000 shares, a decline of 48.5% from the previous total of 262,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does MorphoSys' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MorphoSys: Dr. Reddy's Laboratories Limited (1.97%), Moderna, Inc. (13.72%), Viatris Inc. (3.91%), Ascendis Pharma A/S (12.03%), Qiagen (1.72%), Roivant Sciences Ltd. (11.87%), Lantheus Holdings, Inc. (9.73%), BridgeBio Pharma, Inc. (15.19%), Revolution Medicines, Inc. (10.76%), Legend Biotech Co. (6.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short MorphoSys stock? Short selling MOR is an investing strategy that aims to generate trading profit from MorphoSys as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MorphoSys? A short squeeze for MorphoSys occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MOR, which in turn drives the price of the stock up even further. How often is MorphoSys' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOR, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies RDY Short Interest MRNA Short Interest VTRS Short Interest ASND Short Interest QGEN Short Interest ROIV Short Interest LNTH Short Interest BBIO Short Interest RVMD Short Interest LEGN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MOR) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MorphoSys AG Please log in to your account or sign up in order to add this asset to your watchlist. Share MorphoSys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.